Colgate-Palmolive (India) Ltd
Colgate-Palmolive (India) Ltd
Consumer Goods F&OKey Fundamentals
MidcapPersonal CareConsumer GoodsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Colgate-Palmolive (India) Ltd insights
44 extracted metrics + investor summaries across FY07–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
4- Company has reduced debt.
- Company is almost debt free.
- Company has a good return on equity (ROE) track record: 3 Years ROE 79.4%
- Company has been maintaining a healthy dividend payout of 112%
Weaknesses
2- Stock is trading at 33.7 times its book value
- The company has delivered a poor sales growth of 4.51% over past five years.
Growth Rate
AI Analysis — Bull vs Bear
Colgate-Palmolive (India) is a nearly debt-free FMCG company with a market cap of ₹54,188 Cr, trading at a PE of 40.3x and 34.3x book value. The company delivers exceptional return on equity (83% last year) but has recorded muted sales growth of ~5% CAGR over the past five years and a -2% TTM profit decline.
- Exceptional ROE of 83% in the last year and 79% average over 3 years, indicating highly efficient capital deployment
- Company is virtually debt-free, providing significant financial flexibility and resilience during economic downturns
- Healthy dividend payout ratio of 112%, rewarding shareholders with a 2.39% dividend yield — attractive for income-oriented investors
- Dominant market share in oral care category in India with strong brand recall, providing pricing power and distribution moat
- 10-year compounded profit growth of 8% CAGR demonstrates consistent long-term earnings expansion
- 3-year compounded profit growth of 8% shows sustained earnings momentum even in a challenging FMCG environment
- Parent company Colgate-Palmolive Co provides global R&D support, product innovation pipeline, and operational expertise
- Company has actively reduced debt over time, strengthening the balance sheet further from an already conservative position
- Stock trades at 34.3x book value — among the most expensive valuations in the Indian FMCG space, leaving limited margin of safety
- Compounded sales growth of only 5% over both 3-year and 5-year periods reflects limited top-line expansion in a growing consumer market
- TTM profit growth is negative at -2%, signalling near-term margin or demand pressures
- PE ratio of 40.3x is elevated for a company growing revenue at just 4-5% annually, implying stretched earnings multiples
- Stock CAGR of -8% over the past 1 year and just 1% over 3 years indicates sustained underperformance versus broader market indices
- Narrow product portfolio concentrated primarily in oral care limits diversification and addressable market expansion
- 5-year stock CAGR of only 4% significantly lags the broader Indian equity market returns over the same period
- High dividend payout of 112% exceeds net profits, potentially constraining reinvestment capacity for future growth initiatives
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Q1FY27 sales up 12% YoY Jul 29
Colgate India reported Q1FY27 net sales of ₹1,591 crore, up 12% YoY. Net profit rose 7-11% to ₹343 crore with gross margin expanding 110 bps to 69.7% driven by premium toothpaste growth and cost savings.
- 2025 ESG goals fully achieved Jul 28
Colgate India achieved all 2025 sustainability targets including 100% recyclable toothpaste tubes and 43% carbon reduction. New 2030 SMILE Strategy targets net-zero emissions by 2040 and reaching 245 million more children.
- Investor Day highlights premiumization strategy Aug 17
Colgate shared its investor presentation ahead of the August 17, 2026 Investor Day, highlighting oral care premiumization, toothbrush category growth, personal care expansion, and accelerated Q1FY27 topline growth with strengthening margins.
- 85th AGM resolutions passed Jul 30
All three ordinary resolutions at the 85th AGM held July 29, 2026 were passed with requisite majority, including board appointments and financial statement adoption.
TL;DR: Colgate-Palmolive India is executing well with 12% revenue growth in Q1FY27, margin expansion via premiumization, and strong ESG progress. No material headwinds are visible in recent news flow. The company's strategic pivot toward premium oral care and personal care expansion positions it for continued steady growth, though sustaining double-digit topline momentum will be worth monitoring in coming quarters.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,324 | 1,471 | 1,396 | 1,490 | 1,497 | 1,619 | 1,462 | 1,463 | 1,434 | 1,520 | 1,486 | 1,595 | 1,603 |
| Expenses | 906 | 989 | 927 | 958 | 988 | 1,122 | 1,007 | 964 | 981 | 1,054 | 1,044 | 1,086 | 1,120 |
| Operating Profit | 418 | 482 | 468 | 532 | 508 | 497 | 454 | 498 | 453 | 465 | 442 | 510 | 483 |
| OPM % | 32% | 33% | 34% | 36% | 34% | 31% | 31% | 34% | 32% | 31% | 30% | 32% | 30% |
| Other Income | -5 | 21 | 18 | 23 | 23 | 76 | 20 | 19 | 18 | 15 | 31 | 0 | 19 |
| Interest | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 44 | 44 | 41 | 42 | 42 | 42 | 41 | 38 | 38 | 37 | 36 | 35 | 39 |
| PBT | 369 | 458 | 443 | 511 | 489 | 530 | 433 | 478 | 432 | 442 | 436 | 474 | 462 |
| Tax % | 26% | 26% | 26% | 26% | 26% | 26% | 25% | 26% | 26% | 26% | 26% | 25% | 26% |
| Net Profit | 274 | 340 | 330 | 380 | 364 | 395 | 323 | 355 | 321 | 328 | 324 | 353 | 343 |
| EPS in Rs | 10.06 | 12.5 | 12.14 | 13.96 | 13.38 | 14.52 | 11.87 | 13.05 | 11.79 | 12.04 | 11.91 | 12.99 | 12.61 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,982 | 3,868 | 3,982 | 4,188 | 4,462 | 4,525 | 4,841 | 5,100 | 5,226 | 5,680 | 6,040 | 6,035 | 6,204 |
| Expenses | 3,159 | 2,929 | 3,038 | 3,074 | 3,226 | 3,323 | 3,331 | 3,534 | 3,679 | 3,779 | 4,082 | 4,165 | 4,304 |
| Operating Profit | 823 | 940 | 944 | 1,114 | 1,236 | 1,202 | 1,510 | 1,566 | 1,547 | 1,901 | 1,958 | 1,870 | 1,900 |
| OPM % | 21% | 24% | 24% | 27% | 28% | 27% | 31% | 31% | 30% | 33% | 32% | 31% | 31% |
| Other Income | 32 | 7 | 41 | 26 | 68 | 49 | 30 | 26 | 42 | 57 | 139 | 64 | 66 |
| Interest | 0 | 0 | 0 | 0 | 2 | 10 | 7 | 6 | 5 | 5 | 4 | 4 | 4 |
| Depreciation | 75 | 111 | 133 | 157 | 159 | 198 | 182 | 177 | 175 | 172 | 163 | 146 | 148 |
| PBT | 780 | 835 | 851 | 983 | 1,143 | 1,043 | 1,350 | 1,409 | 1,410 | 1,781 | 1,930 | 1,784 | 1,814 |
| Tax % | 28% | 30% | 32% | 32% | 32% | 22% | 23% | 23% | 26% | 26% | 26% | 26% | — |
| Net Profit | 559 | 581 | 577 | 673 | 776 | 816 | 1,035 | 1,078 | 1,047 | 1,324 | 1,437 | 1,325 | 1,348 |
| EPS in Rs | 20.55 | 21.37 | 21.23 | 24.76 | 28.52 | 30.02 | 38.07 | 39.65 | 38.5 | 48.67 | 52.83 | 48.73 | 49.55 |
| Div. Payout % | 58% | 47% | 47% | 97% | 81% | 93% | 100% | 101% | 101% | 119% | 97% | 119% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 757 | 1,004 | 1,247 | 1,497 | 1,420 | 1,567 | 1,139 | 1,707 | 1,689 | 1,847 | 1,637 | 1,557 |
| Borrowings | 0 | 0 | 0 | 0 | 83 | 102 | 91 | 83 | 69 | 72 | 61 | 47 |
| Other Liabilities | 932 | 972 | 1,037 | 1,039 | 1,097 | 908 | 1,637 | 1,084 | 1,098 | 1,250 | 1,293 | 1,777 |
| Total Liabilities | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,408 |
| Fixed Assets | 782 | 1,008 | 1,108 | 1,146 | 1,191 | 1,123 | 1,065 | 963 | 862 | 794 | 776 | 718 |
| CWIP | 141 | 78 | 167 | 159 | 199 | 190 | 145 | 122 | 114 | 110 | 38 | 27 |
| Investments | 37 | 31 | 31 | 31 | 31 | 19 | 19 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 742 | 885 | 1,005 | 1,228 | 1,206 | 1,272 | 1,666 | 1,817 | 1,907 | 2,292 | 2,204 | 2,663 |
| Total Assets | 1,702 | 2,003 | 2,311 | 2,564 | 2,626 | 2,604 | 2,894 | 2,902 | 2,883 | 3,197 | 3,019 | 3,408 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 638 | 689 | 688 | 694 | 983 | 930 | 784 | 1,626 | 1,176 | 1,199 | 1,394 | 1,806 |
| Investing | -272 | -237 | -342 | -207 | -96 | -19 | 71 | -108 | -8 | 79 | 56 | 374 |
| Financing | -385 | -391 | -341 | -380 | -815 | -891 | -956 | -1,091 | -1,087 | -1,195 | -1,671 | -1,422 |
| Net Cash Flow | -18 | 61 | 5 | 107 | 73 | 20 | -101 | 427 | 82 | 83 | -221 | 758 |
| Free Cash Flow | 339 | 417 | 367 | 485 | 879 | 869 | 727 | 1,576 | 1,107 | 1,123 | 1,323 | 1,730 |
| CFO/OP | 103 | 100 | 105 | 93 | 113 | 104 | 76 | 127 | 101 | 88 | 100 | 121 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 10 | 12 | 18 | 17 | 11 | 9 | 16 | 11 | 11 | 14 | 13 |
| Inventory Days | 63 | 72 | 72 | 56 | 58 | 69 | 79 | 78 | 68 | 63 | 76 | 75 |
| Days Payable | 128 | 136 | 148 | 152 | 144 | 142 | 179 | 169 | 155 | 187 | 185 | 275 |
| Cash Conversion Cycle | -59 | -55 | -63 | -79 | -68 | -63 | -91 | -75 | -76 | -113 | -95 | -188 |
| Working Capital Days | -40 | -43 | -39 | -33 | -36 | -23 | -84 | -25 | -32 | -46 | -37 | -59 |
| ROCE % | 114% | 96% | 74% | 71% | 73% | 65% | 92% | 92% | 79% | 97% | 105% | 108% |
Documents
Frequently Asked Questions about Colgate-Palmolive (India) Ltd
What does Colgate-Palmolive (India) Ltd do?
Where is Colgate-Palmolive (India) Ltd (COLPAL) listed?
Which sector does Colgate-Palmolive (India) Ltd belong to?
What is the market capitalisation of Colgate-Palmolive (India) Ltd?
What is the PE ratio of Colgate-Palmolive (India) Ltd?
What is the 52-week high and low of Colgate-Palmolive (India) Ltd?
Does Colgate-Palmolive (India) Ltd pay dividends?
What is the Return on Equity (ROE) of Colgate-Palmolive (India) Ltd?
How can I research Colgate-Palmolive (India) Ltd on Tapetide?
Company Information
Colgate-Palmolive India Ltd is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products.[1]